ClinicalTrials.govpublic full text
A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis
multiple sclerosis, multiple sclerosis,, demyelinating autoimmune diseases,, interleukin-17,, monoclonal human antibody, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 968091
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.